LLY
Eli Lilly and Company
LLY's fundamentals are strong: revenue grew 46% and it turned 23% of its revenue into free cash flow. At 46x earnings, it's trading in line with its usual 48x. Analysts expect that strong growth to continue.
SLGL
Sol-Gel Technologies Ltd.
There isn't enough reported data to score SLGL yet.
LLY Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| Strong | |
| Healthy |
LLY's revenue, profitability, cash flow and balance sheet are all currently healthy.
SLGL Fundamentals
| Metric | Status |
|---|---|
| Weak | |
| Weak | |
| Stable | |
| Strong |
SLGL's balance sheet is currently strong, and its cash flow is stable, but its revenue and profitability are weak.
LLY PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 27x | $845 | -41% |
| Forward | 30x | $1,427 | — |
| Current | 46x | $1,427 | — |
| Fair | 48x | $1,466 | +2.7% |
| Expensive | 85x | $2,612 | +83% |
Historical ranges are pointers, not guarantees.
LLY's PE is in its fair range at 46x. If earnings grow as analysts expect, today's price would be 30x next year's earnings, in its cheap range.
SLGL PE Valuation
SLGL has no meaningful PE right now: it lost money over the past year.
LLY Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Strong growth | |
| Strongly improving | |
| Limited | |
| Moderate |
Analysts expect strong earnings and revenue growth for LLY, with profitability improving.
SLGL Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses growing | |
| Strong decline | |
| -- | |
| Limited | |
| High |
Analysts expect SLGL's losses to grow, with revenue declining.
LLY Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $46.82 | +52% |
| Q3 2026 | $30.81 | +51% |
| Q2 2026 | $29.80 | +95% |
| Q1 2026 | $28.15 | +129% |
| Q4 2025 | $22.95 | +96% |
| Q3 2025 | $20.44 | +121% |
| Q2 2025 | $15.30 | +88% |
| Q1 2025 | $12.29 | +81% |
| Q4 2024 | $11.71 | +102% |
LLY has the edge over SLGL on earnings quality, reporting a profit while its opponent remains loss making.
SLGL Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q2 2026 | -$5.64 | -$4.38 |
| Q4 2023 | -$10.10 | -$3.64 |
| Q3 2023 | -$10.90 | -765% |
| Q2 2023 | -$10.30 | -379% |
| Q1 2023 | -$8.16 | -3500% |
| Q4 2022 | -$6.46 | -869% |
| Q3 2022 | $1.64 | +$9.20 |
| Q2 2022 | $3.69 | +$15.49 |
SLGL is still losing money, but far less than before: $5.64 per share over the past year, against $15.60 at its worst in late 2019.
LLY Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $24.4B | +39% |
| Q2 2026 | $23B | +48% |
| Q1 2026 | $19.8B | +56% |
| Q4 2025 | $19.3B | +43% |
| Q3 2025 | $17.6B | +54% |
| Q2 2025 | $15.6B | +38% |
| Q1 2025 | $12.7B | +45% |
| Q4 2024 | $13.5B | +45% |
LLY has the edge over SLGL on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 34% | -6.6 points |
| Q2 2026 | 40% | -3.3 points |
| Q1 2026 | 45% | +18 points |
| Q4 2025 | 43% | +5.6 points |
| Q3 2025 | 41% | +27 points |
| Q2 2025 | 44% | +12 points |
| Q1 2025 | 27% | -1.8 points |
| Q4 2024 | 37% | +10 points |
LLY has the edge over SLGL on profitability, with a higher operating margin.
SLGL Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $591K | -97% |
| Q1 2026 | $108K | -90% |
| Q4 2025 | $696K | +150% |
| Q3 2025 | $400K | -93% |
| Q2 2025 | $17.3M | +218% |
| Q1 2025 | $1M | +121% |
| Q4 2024 | $278K | -38% |
| Q3 2024 | $5.4M | +2417% |
SLGL's revenue has slid since its 2021 peak: $591,000 last quarter, down 97% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | -704% | -769 points |
| Q1 2026 | -3569% | -2690 points |
| Q4 2025 | -490% | +1704 points |
| Q3 2025 | -1572% | -1557 points |
| Q2 2025 | 65% | +35 points |
| Q1 2025 | -880% | -2320 points |
| Q4 2024 | -2194% | -984 points |
| Q3 2024 | -15% | +2946 points |
SLGL's operating margin was −704% last quarter, down 769 points from the same quarter a year ago.
LLY Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $8.2B | +22% |
| Q2 2026 | $7.8B | +458% |
| Q1 2026 | $3B | +1826% |
| Q4 2025 | $677.9M | -31% |
| Q3 2025 | $6.7B | +186% |
| Q2 2025 | $1.4B | +476% |
| Q1 2025 | $156.1M | -13% |
| Q4 2024 | $977.8M | +$2.4B |
LLY has the stronger cash trend. Its trailing FCF is up 259% versus its history, compared with SLGL at up 100%.
SLGL Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2024 | $0 | $0 |
| Q1 2024 | $0 | $0 |
| Q4 2023 | $0 | $0 |
| Q3 2023 | $0 | $0 |
| Q2 2023 | $0 | $0 |
| Q1 2023 | $0 | $0 |
| Q4 2022 | $0 | +$15.8M |
| Q3 2022 | $0 | $0 |
SLGL's free cash flow was $0 over the past year, against $0 the year before.
LLY Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | 0% | -300K shares |
| 1 year | -0.6% | -5.4M shares |
| 3 years | -0.7% | -6.4M shares |
| 5 years | -1.9% | -17.4M shares |
| Available history | -4.5% | -42.3M shares |
LLY has the edge over SLGL on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $377M |
| Q2 2026 | $1.6B |
| Q1 2026 | $2.4B |
| Q4 2025 | $1.5B |
| Q3 2025 | $708.1M |
| Q2 2025 | $692.2M |
| Q1 2025 | $1.2B |
| Q4 2024 | $2.1B |
LLY spent $5.8B buying back its own shares over the past year, up 26% from the year before.
SLGL Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +15% | +434K shares |
| 1 year | +17% | +485K shares |
| 3 years | +41% | +958K shares |
| 5 years | +42% | +970K shares |
| Available history | +65% | +1.3M shares |
SLGL has 3M diluted shares, up 17% from a year ago.
| Quarter | Spent |
|---|---|
| Q2 2024 | — |
| Q1 2024 | — |
| Q4 2023 | — |
| Q3 2023 | — |
| Q2 2023 | — |
| Q1 2023 | — |
| Q4 2022 | — |
| Q3 2022 | — |
LLY Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 1.2x | Healthy |
| Q2 2026 | 1.3x | Healthy |
| Q1 2026 | 1.2x | Healthy |
| Q4 2025 | 1.3x | Healthy |
| Q3 2025 | 1.3x | Healthy |
| Q2 2025 | 2.0x | Healthy |
| Q1 2025 | 2.3x | Moderate |
| Q4 2024 | 2.1x | Moderate |
LLY's net debt is about 1.2 years of its operating earnings (EBITDA), about the same as a year ago.
SLGL Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q4 2024 | -10.4x | Net Cash |
| Q3 2024 | -4.8x | Net Cash |
| Q3 2022 | -1.6x | Net Cash |
| Q2 2022 | -0.5x | Net Cash |
| Q1 2022 | -9.2x | Net Cash |
| Q4 2021 | -4.8x | Net Cash |
SLGL has more cash than debt.
LLY Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 68.3 | Neutral |
| Stochastic | 84.1 | Overbought |
LLY's weekly RSI is 68 (neutral) and its Stochastic is 84 (overbought).
SLGL Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 38.7 | Neutral |
| Stochastic | 15.5 | Oversold |
SLGL's weekly RSI is 39 (neutral) and its Stochastic is 16 (oversold).
LLY PE vs Healthcare Sector
| Metric | LLY | Sector median | Relative |
|---|---|---|---|
| PE | 46x | 26x | 79% above |
| PE % | 48 | 29 | 19 pts above |
LLY is trading at 46x earnings, a 79% premium to the Healthcare sector's median of 26x.
SLGL PE vs Healthcare Sector
| Metric | SLGL | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 26x | — |
SLGL has no meaningful PE right now: it lost money over the past year.
LLY Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $1,279.4 | 12% above |
| 20 week MA | $1,218.8 | 17% above |
| 50 week MA | $1,102.2 | 29% above |
| 100 week MA | $954.1 | 50% above |
| 200 week MA | $797.5 | 79% above |
LLY has the edge over SLGL on trend strength, trading above more of its moving averages.
SLGL Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $66.2 | 15% below |
| 20 week MA | $72.0 | 22% below |
| 50 week MA | $69.9 | 20% below |
| 100 week MA | $42.6 | 32% above |
| 200 week MA | $30.7 | 83% above |
SLGL has pulled back, but its long-term trend is still up: it's below its 8-, 20- and 50-week averages, but 83% above its 200-week average.
LLY Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $131.5 | $166.7 | +27% |
| 2021 | $166.7 | $273.1 | +64% |
| 2022 | $273.1 | $367.9 | +35% |
| 2023 | $367.9 | $582.9 | +58% |
| 2024 | $582.9 | $783.2 | +34% |
| 2025 | $783.2 | $1,077.8 | +38% |
| 2026 YTD | $1,077.8 | $1,427.3 | +32% |
LLY has finished every year since 2020 higher, and it's up 32% so far in 2026.
SLGL Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $92.3 | $95.0 | +2.9% |
| 2021 | $95.0 | $67.4 | -29% |
| 2022 | $67.4 | $45.0 | -33% |
| 2023 | $45.0 | $11.1 | -75% |
| 2024 | $11.1 | $11.2 | +0.9% |
| 2025 | $11.2 | $41.9 | +274% |
| 2026 YTD | $41.9 | $56.3 | +34% |
SLGL has the edge over LLY on returns for 2026, with the stronger performance.